A few weeks after Johnson & Johnson announced it would purchase the remainder of Dutch...
Many consumers worldwide believe that personal care products formulated with natural ingredients are better for...
Cosmetics brand Hard Candy will roll out new product categories, shades and technology exclusively at...
The types of websites consumers turn to for health-and-wellness information and the reasons they go...
Ethnic hair care manufacturer Johnson Products Co. has announced the launch of its new touch-up...
Laura Geller Makeup, which is sold on QVC and at CVS' Beauty360, Macy's Impulse and...
Pfizer on Wednesday announced the completion of its acquisition of a privately held drug discovery...
Ranbaxy has won the right to sell a generic version of an Alzheimer’s disease drug...
Sunkist has unveiled its newest way to deliver its liquid shots of protein....
French drug maker Sanofi-Aventis has launched a hostile takeover bid to take over Cambridge, Mass.-based...
Bainbridge & Knight recently announced the launch of its weight-loss diet aid Lichi, an herbal...
Deloitte released a report last week that reaffirmed the latest shopping trend among consumers: private-label...
Global alternative asset manager The Carlyle Group and NBTY on Monday announced that Carlyle has...
A world's leading global music merchandising company and a global children's consumer products sourcing and...
Drug Store News is presenting in November in New York its 12th annual Industry Issues...
Rite Aid and Fuijifilm once again are teaming up to bring customers their annual Picture...
Office desks will never be the same....
Keryx has begun its phase-3 clinicial trial of a drug designed to treat elevated serum...
The subject of specialty pharmacy reached a whole new level of nuance as a wide...
Cirrus Healthcare Products has expanded its ear care offerings with a new product, slated to...
Retail merchants incurred more than $139 billion fraud losses during the past year, according to...
Pfizer has halted a late-stage trial of a drug therapy in men with prostate cancer,...
The Hart-Scott-Rodino waiting period for Bristol-Myers Squibb’s acquisition of Seattle-based biotech company ZymoGenetics has expired,...
Biosimilars, biogenerics, follow-on biologics—whatever the designation one prefers for knockoffs of biotech drugs—they will soon...
As I write this column, it’s the final Super Tuesday primaries in eight states, including...